
Sign up to save your podcasts
Or


Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
By The Goodfellow Unit (University of Auckland)Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.

7,913 Listeners

1,996 Listeners

1,394 Listeners

97 Listeners

3,374 Listeners

113,121 Listeners

272 Listeners

17 Listeners

4 Listeners

1,015 Listeners

8 Listeners

15,506 Listeners

3,858 Listeners

2,131 Listeners

907 Listeners